Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nal-IRI + 5-fluorouracil/leucovorin versus gemcitabine + cisplatin in advanced biliary tract cancer
2016-002467-34Phase 2Completed
- Sponsor
- AIO-Studien
- Start
- Jan 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of nanoliposomal irinotecan, fluorouracil, folinic acid, gemcitabine, cisplatin in biliary adenocarcinoma, cholangiocarcinoma (CCA), gallbladder cancer, sponsored by AIO-Studien. Started Jan 2017; status: completed.
02
Drugs
nanoliposomal irinotecanfluorouracilfolinic acidgemcitabinecisplatin
03
Conditions
biliary adenocarcinomacholangiocarcinoma (CCA)gallbladder cancer
Beyond the preview
Go deeper on 2016-002467-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002467-34.